Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with 68Ga(III) and 45Ti(IV)

IF 4 2区 化学 Q1 BIOCHEMICAL RESEARCH METHODS
Axia Marlin, Phuong Nguyen Tran, Morgan Dierolf, Molly DeLuca, M. Andrey Joaqui Joaqui, Owen M. Glaser, Angus J. Koller, Eduardo Alucio-Sarduy, Mallory Gork, Dariusz Śmiłowicz, Valérie Pierre, Jonathan W. Engle* and Eszter Boros*, 
{"title":"Evaluation of PSMA-Targeted TREN-CAM Conjugates for Targeted Imaging of Cancer with 68Ga(III) and 45Ti(IV)","authors":"Axia Marlin,&nbsp;Phuong Nguyen Tran,&nbsp;Morgan Dierolf,&nbsp;Molly DeLuca,&nbsp;M. Andrey Joaqui Joaqui,&nbsp;Owen M. Glaser,&nbsp;Angus J. Koller,&nbsp;Eduardo Alucio-Sarduy,&nbsp;Mallory Gork,&nbsp;Dariusz Śmiłowicz,&nbsp;Valérie Pierre,&nbsp;Jonathan W. Engle* and Eszter Boros*,&nbsp;","doi":"10.1021/acs.bioconjchem.5c0009910.1021/acs.bioconjchem.5c00099","DOIUrl":null,"url":null,"abstract":"<p >Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup>, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup>, and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> form readily at room temperature within 15 min with a molar activity of 24–29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [<sup>45</sup>Ti][Ti(TREN-CAM-hex-EuE)]<sup>2–</sup>, [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> and [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> complex is observed when compared with that of [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [<sup>68</sup>Ga][Ga(TREN-CAM-hex-KuE)]<sup>3–</sup> is excreted &gt;98% intact, while [<sup>45</sup>Ti][Ti(TREN-CAM-hex-KuE)]<sup>2–</sup> exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for <sup>68</sup>Ga<sup>3+</sup> and <sup>45</sup>Ti<sup>4+</sup> isotopes.</p>","PeriodicalId":29,"journal":{"name":"Bioconjugate Chemistry","volume":"36 4","pages":"859–866 859–866"},"PeriodicalIF":4.0000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioconjugate Chemistry","FirstCategoryId":"1","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.bioconjchem.5c00099","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Chelation approaches that are compatible with a multitude of isotopes are an important area of development. Here, we introduce the design, synthesis, and evaluation of 2,3-dihydroxyterephthalate/catechol chelator conjugates compatible with the positron emission tomography (PET) isotopes 68Ga3+ and 45Ti4+, targeting the prostate-specific membrane antigen (PSMA). The conjugates are made in a multistep organic synthesis incorporating 2,3-dihydroxyterephthalate, linked to the amino hexanoic acid-extended, urea-dipeptides EuE or KuE (substrates of the PSMA active site). The radiochemical complexes, [45Ti][Ti(TREN-CAM-hex-EuE)]2–, [45Ti][Ti(TREN-CAM-hex-KuE)]2–, and [68Ga][Ga(TREN-CAM-hex-KuE)]3– form readily at room temperature within 15 min with a molar activity of 24–29 mCi/μmol. The corresponding chelates are stable in phosphate-buffered saline (PBS) solution prior to injection. Subsequent in vivo studies in a bilateral tumor xenograft mouse model were conducted, including 90- and 270-min PET, followed by biodistribution and metabolite analysis at 2 or 5 h postinjection. These studies demonstrated selective uptake of the radiochemical complexes in the PSMA-expressing tumor (17.25 ± 4.15, 13.84 ± 3.85, 15.64 ± 6.37% ID/g for [45Ti][Ti(TREN-CAM-hex-EuE)]2–, [45Ti][Ti(TREN-CAM-hex-KuE)]2– and [68Ga][Ga(TREN-CAM-hex-KuE)]3– respectively), with pharmacokinetics dominated by renal clearance. Delayed clearance of the [45Ti][Ti(TREN-CAM-hex-KuE)]2– complex is observed when compared with that of [68Ga][Ga(TREN-CAM-hex-KuE)]3– as indicated by elevated activity retention in the blood, which we attribute to the charge difference and partial complex dissociation. Urine metabolite analysis shows that [68Ga][Ga(TREN-CAM-hex-KuE)]3– is excreted >98% intact, while [45Ti][Ti(TREN-CAM-hex-KuE)]2– exhibited signs of dechelation. Conclusively, our data support further investigation of bifunctional TREN-CAM derivatives as a synthetically accessible bifunctional chelator class for 68Ga3+ and 45Ti4+ isotopes.

Abstract Image

68Ga(III)和45Ti(IV)靶向psma靶向的trenn - cam偶联物对肿瘤靶向成像的评价
与多种同位素兼容的螯合方法是一个重要的发展领域。在这里,我们介绍了与正电子发射断层扫描(PET)同位素68Ga3+和45Ti4+兼容的2,3-二羟基对苯二甲酸酯/儿茶酚螯合物的设计、合成和评价,靶向前列腺特异性膜抗原(PSMA)。结合2,3-二羟基对苯二甲酸酯,与氨基己酸延伸的尿素二肽EuE或KuE (PSMA活性位点的底物)连接,通过多步骤有机合成而成。放射化学配合物[45Ti][Ti(trenn - cam - hexhex - eue)]2 -、[45Ti][Ti(trenn - cam - hexhex - kue)]2 -和[68Ga][Ga(trenn - cam - hexhex - kue)]3 -在室温下可在15min内形成,摩尔活性为24 - 29mci /μmol。相应的螯合剂在注射前在磷酸盐缓冲盐水(PBS)溶液中是稳定的。随后在双侧肿瘤异种移植小鼠模型中进行了体内研究,包括90分钟和270分钟PET,然后在注射后2或5小时进行生物分布和代谢物分析。这些研究表明,psma表达的肿瘤可选择性摄取[45Ti][Ti(trenn - cam -hex- eue)]2 -, [45Ti][Ti(trenn - cam -hex- kue)]2 -和[68Ga][Ga(trenn - cam -hex- kue)]3 -的放射化学复合物(分别为17.25±4.15,13.84±3.85,15.64±6.37% ID/g),其药代动力学以肾脏清除为主。与[68Ga][Ga(trenn - cam - hexx - kue)]3 -相比,我们观察到[45Ti][Ti(trenn - cam - hexx - kue)]2 -复合物的清除延迟,这表明血液中活性保留率升高,我们将其归因于电荷差异和部分复合物解离。尿液代谢物分析显示[68Ga][Ga(trenn - cam - hexx - kue)]3 - 98%完整排出,而[45Ti][Ti(trenn - cam - hexx - kue)]2 -有脱羧迹象。最后,我们的数据支持进一步研究双功能trenn - cam衍生物作为68Ga3+和45Ti4+同位素的合成双功能螯合剂类。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioconjugate Chemistry
Bioconjugate Chemistry 生物-化学综合
CiteScore
9.00
自引率
2.10%
发文量
236
审稿时长
1.4 months
期刊介绍: Bioconjugate Chemistry invites original contributions on all research at the interface between man-made and biological materials. The mission of the journal is to communicate to advances in fields including therapeutic delivery, imaging, bionanotechnology, and synthetic biology. Bioconjugate Chemistry is intended to provide a forum for presentation of research relevant to all aspects of bioconjugates, including the preparation, properties and applications of biomolecular conjugates.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信